Informations sur le produit
Nom :
Siguazodan
Synonymes :
- 1-Cyano-2-Methyl-3-[4-(4-Methyl-6-Oxo-1,4,5,6-Tetrahydropyridazin-3-Yl)Phenyl]Guanidine
- Guanidine, N-cyano-N′-methyl-N′′-[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-
- N-Cyano-N'-Methyl-N'-[4-(1,4,5,6-Tetrahydro-4-Methyl-6-Oxo-3-Pyridazinyl)Phenyl]Guanidine
- N-Cyano-Nmethyl-N��-[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]guanidine
- Siguazodan (SKF 94836)
- Siguazodan, N-Cyano-Nμ-methyl-N-[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]guanidine
- Sk And F-94836
- Skf 94836
Description :
Siguazodan is a phosphodiesterase inhibitor that is used for the treatment of congestive heart failure and bowel disease. Siguazodan inhibits the activity of cyclic nucleotide phosphodiesterases, which are enzymes that regulate the concentration of cyclic AMP (cAMP) in cells. It has anti-inflammatory properties and can be used to inhibit the bronchoconstrictor response. Siguazodan also inhibits phosphodiesterase-4 (PDE4), an enzyme that degrades cAMP, increasing intracellular concentrations and causing bronchodilation.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
284.32 g/mol
Formule :
C14H16N6O
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
